Growth hormone isoforms release in response to physiological and pharmacological stimuli.
Ten healthy subjects used to performing regular physical activity and eight subjects affected by idiopathic isolated GH deficiency (GHD) were enrolled; 22- and 20-kDa GH secretion and its biological activity were evaluated in response to pharmacological stimuli such as arginine, L-dopa or glucagon in GHD children, while the hormonal response to exercise was studied according to Bruce protocol in healthy subjects. We found a significant increase in 22- and 20-kDa GH level in healthy subjects after monitored physical exercise (MPE; basal 0.28+/-0.12 vs 7.37+/-2.08 ng/ml and basal 0.076+/-0.04 vs 0.18+/-0.05 ng/ml, respectively). Furthermore, the 22-kDa/20-kDa ratio significantly increased in children who had undergone MPE and the GH bioactivity basal mean value also increased significantly after exercise (basal 2.86+/-0.76 vs 7.64+/-1.9 ng/ml). The mean value of 22-kDa GH in GHD patients increased significantly following GH pharmacological stimulation (2.78+/-0.63 ng/ml) when compared with mean basal (0.20+/-0.11 ng/ml) value. In the GHD group the basal concentration of 20-kDa GH significantly increased following GH pharmacological stimulation (0.34+/-0.11 vs 0.72+/-0.2 ng/ml); the 22-kDa/20-kDa ratio significantly increased too. Likewise, GH bioactivity in children with GHD increased significantly after pharmacological stimulation test (basal 2.53+/-0.56 vs 7.33+/-1.26 ng/ml). Both GH isoform concentrations and their biological activity are significantly increased in healthy subjects after submaximal exercise protocol and in GHD children after pharmacological stimuli.
Pagani
S
S
Department of Pediatric, University of Pavia, 27100 Pavia, Italy.
Cappa
M
M
Meazza
C
C
Ubertini
G
G
Travaglino
P
P
Bozzola
E
E
Bozzola
M
M
D000293:Adolescent; D002648:Child; D004393:Dwarfism, Pituitary / Q000188:drug therapy / Q000378:metabolism; D015444:Exercise / Q000502:physiology*; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D004364:Pharmaceutical Preparations / Q000378:metabolism; D020033:Protein Isoforms / Q000378:metabolism
D004364:Pharmaceutical Preparations; D020033:Protein Isoforms; D019382:Human Growth Hormone; D007980:Levodopa; D005934:Glucagon